FDA safety reviewers are urging a recall of the drug Avandia® due to increased risk of heart attacks. A congressional hearing addressing the safety of Avandia® concluded by alleging that GlaxoSmithKline knew the drug may cause Heart Damage several years before a medical study documented the reports.
Use of denture creams like Poligrip and Fixodent have been found cause neurological disorders due to zinc poisoning. Those who used the product and are suffering from numbness, tingling, muscle weakness or other neurological issues should contact their doctor.
The FDA has warned that Reglan a drug used to treat gastroesophageal reflux disease (GERD) and gastroesophageal reflux (GER) and has been found to cause Tardive Dyskinesia a serious movement disorder.
Yaz and Yasmin are fourth generation birth control pills manufactured by Bayer Healthcare. First approved by the FDA in 2001 (Yasmin) and 2006 (Yaz), there is now increasing concern about the safety of the drugs. The FDA has received reports of more than 50 deaths among Yaz and Yasmin users.
For GSK, already facing more than 800 lawsuits in the United States filed on behalf of children who were born with congenital heart defects as a result of exposure to Paxil in the first trimester, more bad news came this week. Read more »
Diabetics from 18 states who suffered heart attacks or other cardiovascular injuries while taking Avandia only have a short time left to file a claim for compensation. The right to file a claim for compensation is subject to a statute of limitations. Read more »
According to a Dow Jones report, Saudi Arabia has suspended GlaxoSmithKline PLC's (GSK) diabetes drug Avandia from the market for six months. The Saudi authorities found that Avandia's heart risks did not outweigh its benefits. Read more »
In a study published in the British Medical Journal, researchers from the Mayo Clinic after examining more than 200 articles addressing the safety and efficacy of Avandia concluded that, "[a]uthors who had favourable views on the safety of rosiglitazone were more likely to have a financial conflict of intere Read more »
The Food and Drug Administration on February 18, 2009 demanded that manufacturers of Serevent, Advair, Symbicort and Foradil, be required to include new stronger warnings on their labels. Millions of Americans use these drugs to treat asthma. Read more »